Dyslipidemia in type 2 diabetes mellitus

• Hauptverfasser: Stefanović Aleksandra (Verfasst von), Zeljković Aleksandra (Verfasst von), Vekić Jelena (Verfasst von), Spasojević-Kalimanovska Vesna (Verfasst von), Jelić-Ivanović Zorana (Verfasst von), Spasić Slavica (Verfasst von)
• Format: Buch
• Veröffentlicht: Pharmaceutical Association of Serbia, Belgrade, Serbia, 2019-01-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Type 2 diabetes mellitus is a chronic high-prevalence metabolic disease, which is characterized by hyperglycaemia, but also with lipid and protein metabolism disorders. Patients with type 2 diabetes have a high risk for cardiovascular disease (CVD) development and dyslipidemia is considered as a key...